Alexander Kreuter Selected Research

Alexander Kreuter Research Topics

Disease

23	Systemic Scleroderma (Systemic Sclerosis) 01/2021 - 05/2004
21	Neoplasms (Cancer) 11/2021 - 06/2004
13	Melanoma (Melanoma, Malignant) 04/2022 - 05/2009
10	Localized Scleroderma (Morphea) 02/2016 - 02/2002
8	Cutaneous Lupus Erythematosus 04/2022 - 09/2004
8	Fibrosis (Cirrhosis) 01/2021 - 11/2009
7	Lichen Sclerosus et Atrophicus (Lichen Sclerosus) 07/2013 - 02/2002
7	Skin Diseases (Skin Disease) 08/2008 - 02/2002
6	Nephrogenic Fibrosing Dermopathy 01/2012 - 11/2008
4	Skin Neoplasms (Skin Cancer) 04/2022 - 05/2021
4	Neoplasm Metastasis (Metastasis) 01/2022 - 05/2009
4	Carcinoma (Carcinomatosis) 02/2021 - 07/2008
4	Inflammation (Inflammations) 10/2014 - 08/2002
4	Infections 04/2014 - 08/2008
4	Atopic Dermatitis (Atopic Eczema) 07/2013 - 08/2002
4	Psoriasis (Pustulosis Palmaris et Plantaris) 07/2012 - 04/2005
3	Disease Progression 07/2021 - 11/2009
3	Anus Neoplasms (Anal Cancer) 12/2020 - 04/2009
3	Lymphoma (Lymphomas) 10/2020 - 01/2006
3	Pain (Aches) 02/2016 - 10/2004
3	Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous) 01/2014 - 04/2005
3	Ulcer 10/2013 - 07/2008
3	Dysplastic Nevus Syndrome (Dysplastic Nevus) 06/2009 - 05/2009
3	Erythema 03/2009 - 10/2004
2	Brain Neoplasms (Brain Tumor) 01/2022 - 01/2020
2	Pyoderma Gangrenosum 01/2020 - 03/2005
2	Livedoid Vasculopathy 02/2016 - 10/2004
2	Carcinogenesis 05/2015 - 09/2004
2	Connective Tissue Diseases (Connective Tissue Disease) 04/2015 - 09/2004
2	Dermatitis 11/2014 - 07/2013
2	Pruritus (Itching) 06/2014 - 09/2006
2	Systemic Lupus Erythematosus (Libman-Sacks Disease) 07/2013 - 01/2013
2	T-Cell Lymphoma (Lymphoma, T Cell) 05/2013 - 12/2005
2	Leg Ulcer 11/2012 - 01/2011
2	Mucinoses 06/2012 - 06/2011
2	Calciphylaxis 12/2011 - 03/2009
2	Nausea 06/2011 - 03/2009
2	Keloid 05/2011 - 02/2007
2	HIV Infections (HIV Infection) 04/2011 - 12/2006
2	Nevus (Nevi) 06/2009 - 05/2009
2	Kaposi Sarcoma (Kaposi's Sarcoma) 06/2008 - 01/2005
2	Granuloma Annulare 09/2006 - 03/2002
2	Scleromyxedema (Lichen Myxedematosus) 10/2005 - 03/2005
1	Basal Cell Carcinoma (Rodent Ulcer) 04/2022
1	Alopecia (Baldness) 04/2022
1	COVID-19 01/2022
1	Herpes Zoster 01/2022

Drug/Important Bio-Agent (IBA)

10	Proteins (Proteins, Gene)FDA Link 01/2021 - 03/2005
9	DNA (Deoxyribonucleic Acid)IBA 01/2019 - 02/2006
8	Messenger RNA (mRNA)IBA 11/2012 - 10/2006
7	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2020 - 03/2002
5	Biomarkers (Surrogate Marker)IBA 04/2022 - 09/2010
5	Immune Checkpoint InhibitorsIBA 01/2022 - 01/2016
5	CytokinesIBA 10/2017 - 09/2008
5	Imiquimod (Aldara)FDA LinkGeneric 08/2008 - 06/2004
4	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2022 - 01/2018
4	Bleomycin (Blenoxane)FDA LinkGeneric 01/2021 - 05/2015
4	Transforming Growth Factor beta (TGF-beta)IBA 01/2018 - 10/2006
4	Contrast MediaIBA 01/2012 - 10/2009
4	GadoliniumIBA 01/2012 - 10/2009
3	Indicators and Reagents (Reagents)IBA 07/2021 - 05/2011
3	Papillomavirus Vaccines (HPV Vaccines)IBA 02/2021 - 01/2011
3	CollagenIBA 05/2015 - 05/2004
3	Interleukin-6 (Interleukin 6)IBA 12/2012 - 09/2008
3	Antimicrobial PeptidesIBA 11/2012 - 01/2008
3	pimecrolimus (Elidel)FDA Link 09/2006 - 09/2004
3	Intravenous Immunoglobulins (IVIG)FDA Link 01/2005 - 10/2004
2	pembrolizumabIBA 04/2022 - 01/2022
2	IpilimumabIBA 01/2022 - 01/2016
2	NivolumabIBA 01/2022 - 09/2019
2	Type I DNA Topoisomerases (Topoisomerase I)IBA 01/2021 - 01/2018
2	AntibodiesIBA 01/2020 - 03/2013
2	AutoantibodiesIBA 04/2015 - 03/2013
2	InterferonsIBA 10/2014 - 01/2006
2	Anti-Bacterial Agents (Antibiotics)IBA 10/2013 - 03/2009
2	Interleukin-2 (IL2)IBA 07/2013 - 09/2008
2	Interleukin-10 (Interleukin 10)IBA 11/2012 - 09/2008
2	Adenosine Monophosphate (AMP)IBA 11/2012 - 07/2011
2	Interleukin-8 (Interleukin 8)IBA 11/2012 - 09/2008
2	FumaratesIBA 07/2012 - 03/2002
2	Antimalarials (Antimalarial Agents)IBA 06/2011 - 03/2009
2	Methotrexate (Mexate)FDA LinkGeneric 11/2009 - 07/2005
2	DecorinIBA 07/2009 - 06/2007
2	ParaffinIBA 05/2009 - 05/2009
2	liposomal doxorubicin (Doxil)FDA Link 06/2008 - 01/2005
2	Bexarotene (LGD1069)FDA Link 01/2006 - 12/2005
2	Ficusin (Psoralen)IBA 04/2005 - 03/2002
1	HhAntag691IBA 04/2022
1	baricitinibIBA 04/2022

Therapy/Procedure

34	Therapeutics 04/2022 - 02/2002
18	Phototherapy (Light Therapy) 06/2014 - 02/2002
4	Chemoradiotherapy 12/2020 - 04/2009
4	Renal Dialysis (Hemodialysis) 01/2012 - 03/2009
4	Photopheresis 11/2009 - 04/2005
3	Radiotherapy 01/2022 - 04/2015
2	Immunotherapy 01/2022 - 01/2016
2	Transplantation 01/2014 - 01/2011
2	Stem Cell Transplantation 01/2014 - 05/2013
2	Highly Active Antiretroviral Therapy (HAART) 04/2009 - 12/2006
1	Medical Day Care (Partial Hospitalization) 01/2022